Kim Young Ha, Lee Joong Hyuk, Paik Nak Whan, Rho Hyune Mo
Indang Institute of Molecular Biology, Inje University, Seoul, Korea.
DNA Cell Biol. 2006 Jul;25(7):412-7. doi: 10.1089/dna.2006.25.412.
RNA interference (RNAi) is the process of sequence-specific gene silencing induced by 21-23-nt RNA of small interfering RNA (siRNA). The HBx of hepatitis B virus (HBV) causing human liver diseases has been known as a multifunctional protein which affects transcription, cell growth, and apoptotic cell death. Here, we demonstrate that the HBx-specific siRNA (siRNAx) and short hairpin RNA (shRNAx) effectively induce the degradation of HBx mRNA in HBx-transformed and HBV-producing human liver cells by up to 80-90%. Also, the HBx expression in HBx-transformed cells was continuously silenced by retransformation with the shRNAx expression vector. These results imply that HBx-driven RNAi, either delivery of siRNAx or expression of shRNAx, provides a promising anti-HBV approach to suppress the HBx expression in human hepatoma cells.
RNA干扰(RNAi)是由小干扰RNA(siRNA)的21 - 23个核苷酸的RNA诱导的序列特异性基因沉默过程。导致人类肝脏疾病的乙型肝炎病毒(HBV)的X蛋白(HBx)是一种多功能蛋白,可影响转录、细胞生长和细胞凋亡。在此,我们证明HBx特异性siRNA(siRNAx)和短发夹RNA(shRNAx)可有效诱导HBx转化的和产生HBV的人类肝细胞中HBx mRNA的降解,降解率高达80% - 90%。此外,通过用shRNAx表达载体进行再转化,HBx转化细胞中的HBx表达可被持续沉默。这些结果表明,由HBx驱动的RNAi,无论是siRNAx的递送还是shRNAx的表达,都为抑制人类肝癌细胞中HBx的表达提供了一种有前景的抗HBV方法。